These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9305491)

  • 1. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients.
    Uemura N; Oomoto Y; Mukai T; Okamoto S; Yamaguchi S; Mashiba H; Taniyama K; Sasaki N; Sumii K; Haruma K; Kajiyama G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):793-800. PubMed ID: 9305491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
    Uemura N; Okamoto S; Yamamoto S; Matsumura N; Yamaguchi S; Mashiba H; Sasaki N; Taniyama K
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1345-52. PubMed ID: 11012481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
    Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer.
    Nakshabendi IM; Zhang QB; Mokhashi M; Gemmell CG; Lee FD; Russell RI
    Helicobacter; 1996 Sep; 1(3):155-8. PubMed ID: 9398897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
    Suzuki M; Mori M; Miyayama A; Iwai N; Tsunematsu N; Oonuki M; Suzuki H; Hibi T; Ishii H
    J Clin Gastroenterol; 1997; 25 Suppl 1():S222-8. PubMed ID: 9479652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients.
    Noshiro M; Kusugami K; Sakai T; Imada A; Ando T; Ina K; Nobata K; Morise K; Kaneko H; Ito M; Nishio Y
    Scand J Gastroenterol; 2000 May; 35(5):482-9. PubMed ID: 10868450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
    Miyake K; Tsukui T; Shinji Y; Shinoki K; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Gudis K; Iwakiri K; Yamada N; Sakamoto C
    Helicobacter; 2004 Apr; 9(2):130-7. PubMed ID: 15068414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori.
    Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():229-34. PubMed ID: 11966546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis.
    Ando T; Kusugami K; Ohsuga M; Shinoda M; Sakakibara M; Saito H; Fukatsu A; Ichiyama S; Ohta M
    Am J Gastroenterol; 1996 Jun; 91(6):1150-6. PubMed ID: 8651162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
    Graham DY; Genta RM; Graham DP; Crabtree JE
    J Clin Pathol; 1996 Oct; 49(10):829-32. PubMed ID: 8943750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
    Suzuki H; Mori M; Sakaguchi AA; Suzuki M; Miura S; Ishii H
    J Gastroenterol Hepatol; 1998 May; 13(5):516-20. PubMed ID: 9641651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori infection on gastric juice pH.
    Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
    Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
    Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
    Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
    J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
    Vetvik K; Schrumpf E; Mowinckel P; Aase S; Andersen KJ
    Scand J Gastroenterol; 1994 Nov; 29(11):995-1000. PubMed ID: 7871380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
    Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
    Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of Helicobacter pylori infection in patients with duodenal ulcer and chronic liver disease.
    Shahin WA; Abdel-Baset EZ; Nassar AK; Atta MM; Kabil SM; Murray JA
    Scand J Gastroenterol; 2001 May; 36(5):479-84. PubMed ID: 11346200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.